BVXV
Closed
Biondvax Pharmaceuticals Ltd Adr
0.69
+0.05 (+7.81%)
Last Update: 08 Nov 2023 17:30:00
Yesterday: 0.64
Day's Range: 0.6201 - 0.6998
Send
sign up or login to leave a comment!
When Written:
2.16
BiondVax Pharmaceuticals Ltd ADR is a biopharmaceutical company focused on developing universal flu vaccines. The company's lead product candidate, M-001, is designed to provide broad protection against various influenza strains, including both seasonal and pandemic flu. BiondVax's technology is based on a proprietary platform that utilizes a combination of conserved and variable influenza virus antigens to stimulate the immune system. The company is headquartered in Jerusalem, Israel, and its shares trade on the NASDAQ under the ticker symbol BVXV. As of August 2021, BiondVax Pharmaceuticals had a market capitalization of approximately $35 million.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








